Concepedia

Ashley V. Sloan

AV

Statistics

Publications

5

Citations

210

H-Index

5

Active since

2010

Affiliations

Eli Lilly (United States)(Current)

Ashley V. Sloan is an author at Eli Lilly (United States) specializing in enzyme inhibition, drug discovery, and pharmacy.

Publications per year

2010–2020

5

Publications

5

Parathyroid hormone and bisphosphonate have opposite effects on stress fracture repair

Ashley V. Sloan, Joseph R. Martin, Shuo Li et al. · Bone · 2010 · 74 citations

, , +12

Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics

J.G. Luz, Stephen Antonysamy, Steven L. Kuklish et al. · Journal of Medicinal Chemistry · 2015 · 65 citations · Full text

, , +14

Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1

Katherine M. Partridge, Stephen Antonysamy, Shobha Bhattachar et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 27 citations · Full text

, , +6

Characterization of 3,3-dimethyl substituted N-aryl piperidines as potent microsomal prostaglandin E synthase-1 inhibitors

Steven L. Kuklish, Stephen Antonysamy, Shobha Bhattachar et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 26 citations · Full text

, , +11

Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP)

Joseph D. Ho, Matthew R. Lee, Charles T. Rauch et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2020 · 18 citations · Full text

, , +16

1–5 of 5